Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Also explored in the synthesis of antimicrobial agents due to the quinoxaline core’s biological activity. Solubility and stability properties make it suitable for oral drug formulations.